FDA Drug Recalls

Recalls / Class II

Class IID-0610-2022

Product

Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, Distributed by SUPERVALU INC., Eden Prairie, MN 55344 USA. NDC 41163-343-10

Brand name
Equaline Nasal
Generic name
Oxymetazoline Hydrochloride
Active ingredient
Oxymetazoline Hydrochloride
Route
Nasal
NDC
41163-343
FDA application
M012
Affected lot / code info
Batch: 1FK1251, Exp 02/28/2023

Why it was recalled

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Recalling firm

Firm
Perrigo Company PLC
Manufacturer
United Natural Foods, Inc. dba UNFI
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, Allegan, Michigan 49010-9070

Distribution

Quantity
2,664 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-10-26
FDA classified
2022-02-23
Posted by FDA
2022-03-02
Terminated
2023-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0610-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.